CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $51,014,000 | -40.0% | 544,843 | -59.2% | 6.01% | -32.5% |
| Q1 2017 | $84,966,000 | -30.0% | 1,334,467 | -51.1% | 8.90% | -33.2% |
| Q4 2016 | $121,306,000 | -4.7% | 2,730,887 | -22.7% | 13.32% | +8.7% |
| Q3 2016 | $127,310,000 | +216.0% | 3,531,487 | +20.3% | 12.25% | +114.9% |
| Q2 2016 | $40,289,000 | +869.7% | 2,936,487 | +6399.1% | 5.70% | +874.9% |
| Q3 2015 | $4,155,000 | -84.4% | 45,183 | -85.1% | 0.58% | -78.1% |
| Q2 2015 | $26,639,000 | +91.7% | 303,131 | +51.1% | 2.68% | +29.5% |
| Q1 2014 | $13,896,000 | +62.0% | 200,600 | +41.0% | 2.07% | +47.0% |
| Q4 2013 | $8,576,000 | -0.3% | 142,300 | +0.6% | 1.41% | -34.6% |
| Q3 2013 | $8,603,000 | +55.7% | 141,500 | +71.5% | 2.15% | +9.5% |
| Q2 2013 | $5,526,000 | – | 82,500 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |